Showing results (131-140 of 586) with videos related to

Sort By:
Pageof 59
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1992
Error rates in cefoperazone and cefoperazone-sulbactam disk tests with Enterobacteriaceae and Pseudomonas aeruginosaD J Hardy, A L Barry, P C Fuchs, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1979
Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolatesR N Jones, A L Barry, P C Fuchs, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1980
Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicinR N Jones, P C Fuchs, A L Barry, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1994
In-vitro activity of five beta-lactam/beta-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosaJ C McLaughlin, A L Barry, P C Fuchs, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1986
Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease|May 1, 1987
RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteriaP C Fuchs, R N Jones, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease|May 1, 1987
Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicidA L Barry, T L Gavan, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1986
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteriaP C Fuchs, R N Jones, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease|April 1, 1986
In vitro activity of DJ-6783 (a keto carboxylic acid) compared with six other orally administered antimicrobial agentsR N Jones, L W Ayers, A L Barry, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2009
Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility testsR N Jones, A L Barry, C Thornsberry, et al.
Pageof 59